Clinical Trials Logo

Clinical Trial Summary

The primary objective of the study is to establish the correlation between NT-proBNP measurements in fresh human whole blood samples and those in plasma samples from the same study subjects, where said samples are collected in EDTA and Li-Hep anticoagulant tubes and measured by the StatusFirst™ CHF NT-proBNP device in conjunction with the DXpressTM Reader in a laboratory setting.


Clinical Trial Description

n/a


Study Design

Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00734045
Study type Observational
Source Nanogen, Inc.
Contact
Status Completed
Phase N/A
Start date February 2008
Completion date November 2008

See also
  Status Clinical Trial Phase
Withdrawn NCT01744210 - Evaluation of Blood Flow Patterns in Lung Blood Vessels Using Ultrasound Technique in Patients With Congestive Heart Failure N/A
Terminated NCT01831713 - Pulmonary Blood Flow Measurements in CHF Patients N/A
Completed NCT00211874 - Improving Heart Failure Care in Minority Communities N/A
Completed NCT01960907 - Clinical Trials for Elderly Patients With Multiple Disease N/A
Terminated NCT00406575 - Recombinant Human Relaxin for the Treatment of Decompensated CHF Phase 2
Completed NCT00309764 - CHF Management Using Telemedicine N/A
Completed NCT02034045 - Expanding Paramedicine in the Community N/A
Completed NCT01855022 - A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response N/A
Completed NCT02983812 - Developing Enhanced Prediction Models
Completed NCT01044290 - Outlook Quality of Life Intervention Study N/A
Not yet recruiting NCT01414439 - Group Psychotherapy Among Congestive Heart Failure Patients N/A
Approved for marketing NCT00528320 - Clinical Evaluation of Cardiac Resynchronization Therapy (CRT) Using the Ovatio CRT Implantable Cardioverter-defibrillator (ICD) System N/A